Verliglo-M Tablet

Overview Verliglo-M Tablet

Verliglo-M Tablets offer a novel, dual-action nutritional approach, combining L-carnitine and magnesium to restore vital nutrient levels. This unique formulation supports nerve regeneration by supplying essential nutrients for nerve growth. Beneficial for individuals with kidney disease undergoing dialysis, L-carnitine within the formula helps mitigate associated complications, including potential liver, heart, and muscle issues.

Primary Ingredients of Verliglo-M Tablet

• L-Carnitine
• Magnesium

Major Benefits of Verliglo-M Tablet:

• L-carnitine addresses carnitine deficiencies and supports patients with renal impairment undergoing dialysis.
• Individuals unable to effectively utilize dietary carnitine are prescribed this medication. Carnitine deficiency may result in complications affecting the liver, heart, and muscles.
• Vitamin D activation within the body relies on magnesium.
• Magnesium facilitates efficient calcium and phosphate absorption. Insufficient magnesium leads to calcium buildup in muscles, constricting blood vessels and reducing blood flow to deeper areas, such as joints.
• Magnesium plays a vital role in intercellular communication, facilitating the delivery of nutrients systemically.

How to Use Verliglo-M Tablet:

Following your doctor's recommendations

Safety Instruction of Verliglo-M Tablet:

• Always check the product label before administration.
• Keep in a cool, dry location, protected from direct sunlight.
• Store away from children.
• This product likely presents a low risk for the majority of adult users.
• The product, when used as directed, presents no known drawbacks. However, some users may experience mild side effects such as flatulence, constipation, diarrhea, or decreased appetite, particularly during initial treatment.
• Refrain from drinking alcohol.
• Avoid concurrent use of antacids and these supplements.